Persistent Asset Partners’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.4K Buy
+5,915
New +$26.3K 0.01% 543

Other funds holding AQST

Persistent Asset Partners's AQST Position: Q3 2026 in Review

Persistent Asset Partners opened a new position in Aquestive Therapeutics (AQST) in Q3 2026: 5,915 shares worth $27.4K. The stake represents 0.01% of the portfolio and ranks #543 among its holdings.

190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • Persistent Asset Partners held 5,915 shares of Aquestive Therapeutics worth $27.4K as of Q3 2026.
  • Aquestive Therapeutics was a new Persistent Asset Partners position in Q3 2026.
  • Aquestive Therapeutics made up 0.01% of Persistent Asset Partners's portfolio in Q3 2026, its #543 holding.
  • 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.